UnitedHealth (UNH) reported Q3 FY 2017 earnings of $2.66 per share (versus $2.17 in Q3 FY 2016), beating analysts' consensus estimate of $2.57.
The company's quarterly revenues amounted to $50.322 bln (+8.7% y/y), generally in-line with analysts' consensus estimate of $50.383 bln.
The company also raised guidance for FY2017, projecting EPS approaching $10.00 (prior $9.75-9.90) versus analysts' consensus estimate of $9.86.
UNH rose to $196.00 (+1.45%) in pre-market trading.